Superworth

Atossa Therapeutics EPS ATOS

Diluted earnings per share by quarter and over the last twelve months, from 2011.

Last 12 months, to Jun 30, 2026
−$4.38
Latest quarter, Q2 FY26
−$0.95
Fiscal year 2025
−$4.08

Atossa Therapeutics' earnings per share was −$4.38 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.95.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$4.08n/a
FY2024−$3.15n/a
FY2023−$3.60n/a
FY2021−$2.70n/a
FY2020−$27.15n/a
FY2019−$31.05n/a
FY2018−$218.55n/a
FY2017−$244.05n/a
FY2016−$405.00n/a
FY2015−$1447.20n/a
FY2014−$1620.00n/a
FY2013−$1836.00n/a
FY2012−$1080.00n/a
FY2011n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.95n/a−$4.38
Q1 FY26−$1.11n/a−$4.41
Q4 FY25−$1.27n/a−$4.08
Q3 FY25−$1.05n/a−$3.56
Q2 FY25−$0.98n/a−$3.41
Q1 FY25−$0.78n/a−$3.18
Q4 FY24−$0.75n/a−$3.15
Q3 FY24−$0.90n/a−$3.30
Q2 FY24−$0.75n/a−$3.15
Q1 FY24−$0.75n/a−$3.60
Q4 FY23−$0.90n/a−$3.60
Q3 FY23−$0.75n/an/a

Against its peers

Companies in Drug Manufacturers - General nearest Atossa Therapeutics' size, closest first, today.

CompanyEPS, 12 monthsGrowth
ATOSAtossa Therapeutics−$4.38
ATNMActinium Pharmaceuticals$0.36
SPROSpero Therapeutics$0.11
LFVNLifevantage$0.40−46% a year
NATRNatures Sunshine Products$1.01+36% a year
Peer median$0.38

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Atossa Therapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.